HOME STORY OF OUR FIRM SEARCH
ASBESTOS DRUGS POLLUTANTS ACCIDENTS MALPRACTICE
English En Français

FREE LEGAL REVIEW

First Name
Last Name
Home Phone
Work Phone
City and State
Email
Were you diagnosed with Asbestosis? Yes
Were you diagnosed with lung cancer? Yes
Were you diagnosed with Mesothelioma? yes
What is your date of diagnosis?
Additional Comments
Best time to call?

David N. Weissman, M.D.’s Testimony: Research on Asbestos Related Disease

Read more from the testimony of Dr. Weissman, who spoke before the Senate’s Committee on the Environment and Public Works about the dangers of asbestos. In this section, he discusses research on the detection of asbestos-related respiratory diseases.

NIOSH is pursuing research relevant to the detection of asbestos-related respiratory diseases. Traditionally, film-based chest radiographs have been used in epidemiological studies evaluating workers for pulmonary and pleural disease associated with asbestos exposure.

This is because only film-based chest radiographs may be systematically classified for changes of dust-induced lung disease (pneumoconiosis) using the widely accepted International Labour Organization (ILO) classification system.

However, in the United States, digital chest radiography has largely replaced film-based radiography.

NIOSH has funded research to evaluate the impact of classifying digital, instead of film-based, chest x-rays on the detection and classification of pulmonary and pleural disease.

Initial results suggest that the two methods do not differ significantly in detection of interstitial (lung tissue) processes, but do differ in detection of pleural processes, with fewer pleural changes detected in those undergoing digital chest radiography.

In follow up to this finding, NIOSH is assisting ATSDR in performing a study to compare detection of pleural changes in those exposed to Libby amphibole by film-based and digital radiography, with findings of computed tomography scans of the chest serving as a “gold standard.”

In 2006, NIOSH published a Recommended Exposure Limit (REL) for another type of inorganic fiber, refractory ceramic fibers (RCF).

Although RCF are man-made fibers which differ from asbestos in toxicity, many of the same issues relevant to asbestos such as fiber length, diameter, and biopersistence were considered in developing the NIOSH REL of 0.5 fibers per cc.

Courtesy of the U.S. Department of Health and Human Services (HHS): http://www.hhs.gov/asl/testify/2007/06/t20070612c.html

Courtesy of EPA

Other helpful links:

Asbestos Asbestos
Asbestos and lung cancer Asbestos and lung cancer
Mesothelioma attorney Mesothelioma attorney
Mesothelioma Lawyer Mesothelioma lawyer
Asbestos attorney Asbestos attorney

Mesothelioma Mesothelioma Home Page
head Mesothelioma: An Overview
kleio The Clock Is Ticking
asbestos Our Toughest Cases
head Diagnosis
treatment Symptoms, Stages, Treatment
kleio Latest News
New York Numbers
Asbestos
Real Stories


IN THIS SECTION
Testimony from Dr. Weissman on asbestos
Mesothelioma: NIOSH
NIOSH’s Dr. Weissman on asbestos related disease
Dr. Weisman on rise in asbestos mortality rate
Dr. Weisman explains danger of asbestos exposure
limiting asbestos exposure
Dr. Weisman testimony on asbestos-caused disease
Dr. Weisman testimony on asbestos-related diseases
Dr. Weissman of NIOSH on institute’s asbestos aim
Dr. Weissman on asbestos cancers in Libby, MT
Dr. Weissman discusses dangers of asbestos fibers
Dr. Weissman on asbestos exposure assessment
Dr. Weissman on asbestos-related health research
Dr. Weissman talks on asbestos and mineral fibers
Dr. Weissman talks on asbestos and minerals
Dr. Weissman on asbestos fiber dimensions
Final comments by Dr. Weissman on asbestos dangers


RETURN BACK TO
Mesothelioma
Mesothelioma Resource Center
Asbestos
Asbestos Exposure Dangers
Asbestos Help
News & Warnings
Official Documents

Mesothelioma Lawyer

Asbestos Lawyer

Mesothelioma Attorney

Asbestos Attorney

For legal help anywhere in the U.S. call:

1 - 800 - 476 - 6070

Prior results do not guarantee a similar outcome.

ATTORNEY ADVERTISING

see also:

Testimony from Dr. Weissman on asbestos Dr. Weissman’s Senate testimony on the background history of asbestos
Senate testimony by NIOSH’s Dr. Weissman on asbestos health dangers

Dr. Weissman on asbestos cancers in Libby, MT Dr. Weissman discusses epidemic of asbestos-caused cancer in Libby, MT
Dr. Weissman testimony on asbestos cancer epidemic in Libby, MT

NIOSH’s on asbestos health dangers NIOSH’s Dr. Weissman testifies on health dangers of asbestos exposure
Senate Committee testimony by Dr. Weissman on asbestos health dangers